Physiologically important secondary modifications of red cell membrane in hereditary spherocytosis-evidence for in vivo oxidation and lipid rafts protein variations

Blood Cells, Molecules, and Diseases

Volumn 38, Issue 3, 2007, Pages 210-220

  Margetis, Panagiotis ^a   Antonelou, Marianna ^a   Karababa, Fotini ^b   Loutradi, Afroditi ^b   Margaritis, Lukas ^a   Papassideri, Issidora ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b IASO GENERAL HOSPITAL   (Greece)

Author keywords

Carbonylation; Hemoglobin oxidation; Hereditary spherocytosis; Lipid rafts; Opsonization

Indexed keywords

ANKYRIN; ERYTHROCYTE BAND 3 PROTEIN; ERYTHROCYTE BAND 4.2 PROTEIN; HEMOGLOBIN; IMMUNOGLOBULIN G; PROTEIN ANTIBODY; SPECTRIN;

ADULT; ARTICLE; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; CYTOSKELETON; ERYTHROCYTE MEMBRANE; HEREDITARY SPHEROCYTOSIS; HUMAN; IMMUNOBLOTTING; IN VIVO STUDY; LIPID RAFT; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DEFICIENCY; PROTEIN DEGRADATION; PROTEIN DENATURATION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOSKELETON; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FEMALE; HEMOGLOBINS; HUMANS; MALE; MEMBRANE LIPIDS; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; MIDDLE AGED; OXIDATION-REDUCTION; SPHEROCYTOSIS, HEREDITARY;

EID: 34047191022     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2006.10.163     Document Type: Article

References (48)

1. Gallagher P.G. Red cell membrane disorders. Hematology (Am. Soc. Hematol. Educ. Program) (2005) 13-18
2. Inaba M., Yawata A., Koshino I., et al. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. J. Clin. Invest. 97 (1996) 1804-1817
3. Lux S.E., and Palek J. Disorders of the red cell membrane. In: Handin R.I., Lux S.E., and Stossel T.P. (Eds). Blood: Principles and Practice of Hematology (1995), JB Lippincott Co., Philadelphia 1701-1818
4. Sheetz M.P., Schindler M., and Koppel D.E. Lateral mobility of integral membrane proteins is increased in spherocytic erythrocytes. Nature 285 (1980) 510-511
5. Peters L.L., Shivdasani R.A., Liu S.-C., et al. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss and not to form the membrane skeleton. Cell 86 (1996) 917-927
6. Rettig M.P., Low P.S., Gimm J.A., et al. Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. Blood 93 (1999) 376-384
7. Cappellini M.D., Tavazzi D., Duca L., et al. Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia. Br. J. Haematol. 104 3 (1999) 504-512
8. Reinhardt D., Witt O., Miosge N., et al. Increase in band 3 density and aggregation in hereditary spherocytosis. Blood Cells Mol. Dis. 27 (2001) 399-406
9. Rocha S., Rebelo I., Costa E., et al. Protein deficiency balance as a predictor of clinical outcome in hereditary spherocytosis. Eur. J. Haematol. 74 (2005) 374-380
10. Caprari P., Bozzi A., Ferroni L., et al. Oxidative erythrocyte membrane damage in hereditary spherocytosis. Biochem. Int. 26 (1992) 265-274
11. Salzer U., and Prohaska R. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 97 (2001) 1141-1143
12. ++-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 99 (2002) 2569-2577
13. LELY, a low expression allele of the gene encoding erythroid spectrin α-chain, in the Greek population. Haematologica 84 (1999) 754-755
14. Premetis E., Stamoulakatou A., and Loukopoulos D. Erythropoiesis: hereditary spherocytosis in Greece: collective data on a large number of patients. Hematology 4 (1999) 361-366
15. Dodge J.T., Mitchell C., and Hanahan D.J. The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100 (1963) 119-130
16. Mueller T.J., Jackson C.W., Dockter M.E., and Morrison M. Membrane skeletal alterations during in vivo mouse red cell aging. Increase in the band 4.1a:4.1b ratio. J. Clin. Invest. 79 (1987) 492-499
17. Bradford M.N. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
18. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
19. Fairbanks G., Steck T.L., and Wallach D.F.H. Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 10 (1971) 2606-2617
20. Kriebardis A.G., Antonelou M.H., Stamoulis K.E., et al. Membrane protein carbonylation in non-leukodepleted CPDA-preserved red blood cells. Blood Cells Mol. Dis. 36 (2006) 279-282
21. Dalla Libera L., Ravara B., Gobbo V., et al. Skeletal muscle myofibrillar protein oxidation in heart failure and the protective effect of Carvedilol. J. Mol. Cell. Cardiol. 38 (2005) 803-807
22. Inaba M., and Maede Y. Correlation between protein 4.1a/4.1b ratio and erythrocyte life span. Biochim. Biophys. Acta 944 (1988) 256-264
23. Antonelou M.H., Papassideri I.S., Karababa F.J., et al. Defective organization of the erythroid cell membrane in a novel case of congenital anemia. Blood Cells Mol. Dis. 30 (2003) 43-54
24. Allan D., Thomas P., and Limbrick A.R. The isolation and characterization of 60 nm vesicles ("nanovesicles") produced during ionophore A23187-induced budding of human erythrocytes. Biochem. J. 188 (1980) 881-887
25. Orntoft T.F., and Clausen N. Hereditary spherocytosis: diagnostic and anemia-associated aberrations of ghost proteins. Scand. J. Clin. Lab. Invest. 54 (1994) 95-103
26. Rybicki A.C., Heath R., Wolf J.L., et al. Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia. Evidence for a role of protein 4.2 in stabilizing ankyrin on the membrane. J. Clin. Invest. 81 3 (1988) 893-901
27. Advani R., Sorenson S., Shinar E., et al. Characterization and comparison of the red blood cell membrane damage in severe human α- and β-thalassemia. Blood 79 (1992) 1058-1563
28. Allen D.W., Cadman S., McCann S.R., and Finkel B. Increased membrane binding of erythrocyte catalase in hereditary spherocytosis and in metabolically stressed normal cells. Blood 49 (1977) 113-123
29. McMillan D.C., Powell C.L., Bowman Z.S., et al. Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents. Toxicol. Sci. 88 (2005) 74-83
30. Snyder L.M., Fortier N.L., Trainor J., et al. Effect of hydrogen peroxide exposure on normal human erythrocyte deformability, morphology, surface characteristics and spectrin-hemoglobin cross-linking. J. Clin. Invest. 76 (1985) 1971-1977
31. Palek J., Liu S.-C., and Snyder L.M. Metabolic dependence of protein arrangement in human erythrocyte membranes. I. Analysis of spectrin-rich complexes in ATP-depleted red cells. Blood 51 3 (1978) 385-395
32. Allen D.W., and Cadman S. Calcium-induced erythrocyte membrane changes. Biochim. Biophys. Acta 551 1 (1979) 1-9
33. Bratosin D., Estaquier J., Petit F., et al. Programmed cell death in mature erythrocytes: a model for investigating death effector pathways operating in the absence of mitochondria. Cell Death Differ. 8 (2001) 1143-1156
34. Nunomura W., and Takakuwa Y. Regulation of protein 4.1R interactions with membrane proteins by Ca2+ and calmodulin. Front. Biosci. 11 (2006) 1522-1539
35. Friederichs E., and Meiselman H.J. Effects of calcium permeabilization on RBC rheologic behaviour. Biorheology 31 (1994) 207-215
36. 2+ influx in normal and spherocytic red cells. Clin. Chim. Acta 174 (1988) 141-148
37. Knowles D.W., Tilley L., Mohandas N., and Chasis JA. Erythrocyte membrane vesiculation: model for the molecular mechanism of protein sorting. Proc. Natl. Acad. Sci. 94 (1997) 12969-12974
38. Fortier N., Snyder L.M., Garver F., et al. The relationship between in vivo generated hemoglobin skeletal protein complex and increased red cell membrane rigidity. Blood 71 (1988) 1427-1431
39. Mansouri A., and Perry C.A. Hemoglobin autooxidation at physiological concentrations. Hemoglobin 11 (1987) 353-371
40. Becker P.S., Morrow J.S., and Lux S.E. Abnormal oxidant sensitivity and beta-chain structure of spectrin in hereditary spherocytosis associated with defective spectrin-protein 4.1 binding. J. Clin. Invest. 80 (1987) 557-565
41. Kiefer C.R., and Snyder L.M. Oxidation and erythrocyte senescence. Curr. Opin. Hematol. 7 (2000) 113-116
42. Snyder L.M., Leb L., Piotrowski J., et al. Irreversible spectrin-haemoglobin crosslinking in vivo: a marker for red cell senescence. Br. J. Haematol. 53 (1983) 379-384
43. Dalle-Donne I., Rossi R., Giustrarini D., et al. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chem. Acta 329 (2003) 23-38
44. Becker P.S., Cohen C.M., and Lux S.E. The effect of mild diamide oxidation on the structure and function of human erythrocyte spectrin. J. Biol. Chem. 261 (1986) 4620-4628
45. Wagner G.M., Chiu D.T., Yee M.C., and Lubin B.H. Red cell vesiculation-A common membrane physiological event. J. Lab. Clin. Med. 108 (1986) 315-324
46. Reliene R., Mariani M., Zanella A., et al. Splenectomy prolongs in vivo survival of erythrocytes differently in spectrin/ankyrin- and band 3-deficient hereditary spherocytosis. Blood 100 (2002) 2208-2215
47. Li C.K., Ng M.H., Cheung K.L., et al. Interaction of hereditary sperocytosis and alpha thalassaemia: a family study. Acta Haematol. 91 4 (1994) 201-205
48. J. Delaunay, The molecular basis of hereditary red cell membrane disorders, Blood Rev. Article, (in press). doi:10.1016/j.bire.2006.03.005.